Literature DB >> 32494563

Food intolerance/malabsorption may occur in rare diseases.

Wolfgang J Schnedl1, Manfred Tillich2, Michael Schenk3, Dietmar Enko4, Harald Mangge4.   

Abstract

Sugars including lactose and fructose, or proteins (gluten), or biogenic amines (histamine), and combinations thereof may cause food intolerance/malabsorption. However, in usually asymptomatic patients with rare diseases, who present with functional, non-specific, non-allergic gastrointestinal (GI) complaints the etiologic factors of food intolerance/malabsorption need to be evaluated. We summarize patients with rare diseases, such as primary epiploic appendagitis, beta-thalassemias minor, Gullo syndrome and anomaly of the inferior vena cava, who presented functional, non-specific, non-allergic GI complaints. As conclusion, these GI symptoms in patients with otherwise asymptomatic, rare diseases were due to fructose malabsorption, histamine-, lactose intolerance and Helicobacter pylori (H.p.) infection. A registered and experienced dietician was employed to design an individually-tailored diet which ensured effective treatments and H.p. infection was accordingly eradicated. 2020, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  histamine; primary epiploic appendagitis; Gullo syndrome; beta-thalassemia minor; inferior vena cava anomaly; lactose; fructose

Year:  2020        PMID: 32494563      PMCID: PMC7263995          DOI: 10.5582/irdr.2020.01029

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  2 in total

Review 1.  Histamine Intolerance Originates in the Gut.

Authors:  Wolfgang J Schnedl; Dietmar Enko
Journal:  Nutrients       Date:  2021-04-12       Impact factor: 5.717

2.  Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen.

Authors:  Wolfgang J Schnedl; Nathalie Meier-Allard; Michael Schenk; Sonja Lackner; Dietmar Enko; Harald Mangge; Sandra J Holasek
Journal:  EXCLI J       Date:  2022-02-17       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.